PDS Biotechnology (PDSB) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PDS Biotechnology (PDSB) has outperformed ProMIS Neurosciences (PMN) over the past year, gaining 10.5% versus a loss of 32.4%. Over five years, PDSB leads with a -91.4% price change compared with -95.9% for PMN. ProMIS Neurosciences is the larger company by market cap ($83.2 million vs $75.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDSB | PMN |
|---|---|---|
| Share price | $1.05 | $9.28 |
| Market cap | $75.74M | $83.19M |
| 1-day change | -1.88% | +1.72% |
| YTD return | +38.31% | +33.53% |
| 1-year return | +10.48% | -32.44% |
| 5-year return | -91.36% | -95.95% |
| EPS (TTM) | $-0.65 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.55 | $27.40 |
| 52-week low | $0.195 | $6.27 |
| Distance from 52-week high | -32.58% | -66.14% |
| Average volume | 23.18M | 84.01K |
| Shares outstanding | 72.47M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDSB has outperformed PMN by 42.9 percentage points over the past year.
PDSB vs PMN FAQ
Which is bigger, PDS Biotechnology or ProMIS Neurosciences?
ProMIS Neurosciences (PMN) is larger, with a market capitalization of $83.19M compared with $75.74M for PDS Biotechnology (PDSB).
Which stock has performed better over the past year, PDSB or PMN?
PDSB returned +10.48% over the past 12 months, compared with -32.44% for PMN (price return, excluding dividends). Past performance does not predict future results.
Are PDS Biotechnology and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.